Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 06 - 13 entities : Eli lilly and company save search
FDA Approves First Systemic Treatment for Alopecia Areata
Published: 2022-06-13 (Crawled : 20:00) - fda.gov
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -0.49%
H: 0.98%
C: 0.56%
treatment fda
Global Cytotoxic Drugs Market Estimated to Reach $14,885.2 Million by 2028 and Grow at 1.2% CAGR in the 2021-2028 Timeframe [202-Pages] | Report by Research Dive
Published: 2022-06-13 (Crawled : 13:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: -4.56%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: -1.86%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
ABBV | News | $167.89 0.89% 0.0% 5.6M
|
Health Technology
|
| O: -2.38%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
research report market
Akari Therapeutics Announces the Appointment of Accomplished Biotech Executive Melissa Bradford-Klug as Chief Operating Officer to Lead Business Development and Company Growth Strategies
Published: 2022-06-13 (Crawled : 12:20) - biospace.com/
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
AKTX | $1.2 2.9% 2.82% 14K
|
Health Technology
|
| O: -0.99%
H: 3.0%
C: -1.1%
biotech therapeutics growth
IASO Bio and Innovent Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022
Published: 2022-06-13 (Crawled : 02:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
|
| O: -3.69%
H: 0.0%
C: 0.0%
car-t therapy
Innovent Releases Results of High-dose Cohorts in Phase 1 Clinical Study of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity at ENDO 2022
Published: 2022-06-13 (Crawled : 01:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
|
| O: -3.69%
H: 0.0%
C: 0.0%
ibi362 obesity chinese results phase 1
Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022
Published: 2022-06-13 (Crawled : 01:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
|
| O: -3.69%
H: 0.0%
C: 0.0%
car-t therapy
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.